Financials
- Market Capitalization 1.74 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-63.19
市销率
15.2
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2076 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.32 USD | -0.30% | -5.14% | +9.57% | -29.36% | 1.78 B USD | ||
| 2084 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.54 USD | -1.18% | -4.57% | +18.41% | -8.60% | 1.76 B USD | ||
| 2095 | FTRE Fortrea Holdings Inc. - Common Stock | 18.22 USD | +2.82% | -0.49% | -5.30% | +76.21% | 1.73 B USD | ||
| 2106 | GHRS GH Research PLC - Ordinary Shares | 27.61 USD | +0.91% | -4.20% | -1.99% | +94.99% | 1.71 B USD |